Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs Acquiring UK Lyophilized Reagent Maker Fluorogenics

NEW YORK – Life science reagents supplier New England Biolabs said on Monday that it has agreed to acquire UK-based lyophilization R&D service company Fluorogenics.

Under the terms of the agreement, Fluorogenics will become a wholly-owned subsidiary of NEB and be part of its OEM and Customized Solutions business. Financial terms of the deal were not disclosed.

NEB currently supplies research-use-only reagents that its customers can use for further development and validation in diagnostic assays. The company said it is looking to increase its ability to offer lyophilized reagents that can withstand ambient shipping and storage.

"The acquisition of [Fluorogenics] enables NEB to combine our expertise in enzyme manufacturing and assay development with their expertise in lyophilization, providing a complete solution for our customers," NEB CEO Jim Ellard said in a statement. "It also further solidifies our ability to service customers in the molecular diagnostics space."

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.